# FDA Inspection 1089913 - GEV Co Ltd - April 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/gev-co-ltd/63db5556-e0f1-4a03-b355-5ad2ab342cc4
Source feed: FDA_Inspections

> FDA Inspection 1089913 for GEV Co Ltd on April 16, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1089913
- Company Name: GEV Co Ltd
- Inspection Date: 2019-04-16
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1294010 - 2025-09-17](https://www.keypedia.com/records/fda_inspections/gev-co-ltd/1ccda0b6-43e9-4b95-9247-5332ad4baedf)
- [FDA Inspection 1294010 - 2025-09-17](https://www.keypedia.com/records/fda_inspections/gev-co-ltd/ccc5fbe4-d55c-47be-969f-a3443dc9e3e1)
- [FDA Inspection 1218362 - 2023-09-06](https://www.keypedia.com/records/fda_inspections/gev-co-ltd/0ad29a84-2ef6-4b2c-b97d-2405786c3dc2)
- [FDA Inspection 890859 - 2014-05-27](https://www.keypedia.com/records/fda_inspections/gev-co-ltd/5136401b-21cd-40fe-86da-de384fc2600a)

Company: https://www.keypedia.com/companies/gev-co-ltd/57ed3934-8ae9-41da-b8cb-f97167ed5014

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d